Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nexavar and Intrahepatic Chemotherapy in HCC
NCT00875615Phase 2Completed
- Sponsor
- University of Miami
- Start
- Dec 2008
- Primary completion
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by University of Miami. Started Dec 2008; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00875615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00875615.